CVS Health Corporation $CVS Stock: Pictet Asset Management Holding SA Grows Stake

Pictet Asset Management Holding SA lifted its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 31.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,072,981 shares of the pharmacy operator's stock after purchasing an additional 255,680 shares during the quarter. Pictet Asset Management Holding SA owned 0.08% of CVS Health worth $91,951,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in CVS Health during the second quarter worth about $12,747,462,000. State Street Corp increased its holdings in CVS Health by 26.3% in the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator's stock valued at $7,751,205,000 after buying an additional 15,604,883 shares during the period. Bank of America Corp DE increased its holdings in CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator's stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the period. Pzena Investment Management LLC acquired a new position in shares of CVS Health in the 2nd quarter valued at approximately $1,217,558,000. Finally, Wellington Management Group LLP raised its position in shares of CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator's stock valued at $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Insider Activity

In related news, EVP Prem Shah purchased 23,855 shares of the stock in a transaction dated Friday, November 6th. The stock was bought at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president owned 88,516 shares of the company's stock, valued at approximately $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.85% of the company's stock.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: An executive bought about $2 million of CVS stock, a notable insider purchase that may signal confidence in the company’s outlook. Insider Buying: CVS Health EVP Buys $2,001,195.95 in Stock
• Positive Sentiment: CVS’s latest quarter beat analyst estimates for earnings and revenue. Management cited pharmacy strength, progress in Medicare margin recovery, improvement in its medical benefit ratio and solid cash generation—supportive signs for its operating outlook. The top 5 analyst questions from CVS Health’s Q3 2026 earnings call
• Neutral Sentiment: CVS’s planned separation into two entities is being framed as potentially beneficial to shareholders, but Mark Cuban argued it would do little for patients and called for legislation targeting healthcare monopolies. The breakup’s financial benefits remain a key investor question. Mark Cuban on the CVS breakup
• Neutral Sentiment: A reported $2.1 million settlement is small relative to CVS’s scale, so its direct financial impact appears limited. CVS settlement will see $2.1 million paid out
• Negative Sentiment: CVS is challenging Tennessee’s law barring pharmacies from owning pharmacy benefit managers. The dispute adds regulatory uncertainty around its integrated business model, even as the company says pharmacy services will continue uninterrupted. CVS Health challenges Tennessee PBM ownership ban in federal court

CVS Health Trading Up 1.6%

Shares of CVS Health stock opened at $85.16 on Tuesday. The firm has a market capitalization of $108.92 billion, a PE ratio of 9.91, a price-to-earnings-growth ratio of 0.73 and a beta of 0.58. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The firm's 50 day moving average is $90.21 and its 200 day moving average is $88.91. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion during the quarter, compared to analysts' expectations of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm's quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.60 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.25 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health's payout ratio is presently 30.97%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several analyst reports. UBS Group reduced their price target on shares of CVS Health from $118.00 to $107.00 and set a "buy" rating on the stock in a research report on Thursday, November 5th. Barclays lowered their price objective on shares of CVS Health from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Thursday, November 5th. Piper Sandler set a $112.00 target price on CVS Health in a research note on Wednesday, September 9th. Raymond James Financial set a $103.00 target price on CVS Health in a report on Friday. Finally, Weiss Ratings lowered CVS Health from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday, October 9th. Twenty-two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $108.25.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.